首页> 外文期刊>The Internet Journal of Nephrology >Profile Of Cardiovascular Disease Risk Factors In Normoalbuminuric Nigerian Diabetic Patients.
【24h】

Profile Of Cardiovascular Disease Risk Factors In Normoalbuminuric Nigerian Diabetic Patients.

机译:正常白蛋白尿尼日利亚糖尿病患者心血管疾病危险因素的概况。

获取原文
           

摘要

BackgroundNephropathy in patients with Diabetes Mellitus is usually progressive, commencing with microalbuminuria and progressing to macroalbuminuria with subsequent development of progressive reduction of glomerular filtration rate. The development of microalbuminuria also substantially increases the risk of cardiovascular morbidity and mortality in the diabetic patients. Recent studies have indicated that substantial cardiovascular risk may exist in patients having proteinuria in the range currently considered to be normal. This risk appears to increase as the level of albuminuria increases in this setting. However, racial and genetic influences on these observations are not known.MethodsThis cross-sectional study, describes the profile of cardiovascular risk factors in 150 normoalbuminuric African diabetic patients with regular clinic attendance at the diabetic clinic of a Teaching Hospital in Lagos, Nigeria. ResultsOne hundred and thirty (86.67%) of the 150 studied subjects had one or more cardiovascular risk factors that did not correlate with the degree of albumin excretion. 50% of the studied subjects were hypertensive, 37.3% were obese, hypercholesterolaemia occurred in 13.3%, elevated LDL in 20% and low HDL in 35.3% of the subjects. Mean duration of diabetes was 6.8yrs.ConclusionsIt was concluded that there is a high background prevalence of Cardiovascular Disease risk factors in these normoalbuminuric Diabetic subjects with short duration of diabetes. This finding is a reflection of the huge Cardiovascular Disease burden in this population of patients. Background Diabetes Mellitus is an important cardiovascular disease risk factor and various studies have shown an increased prevalence of cardiovascular diseases such as coronary artery disease, stroke, peripheral vascular disease and congestive cardiac failure in diabetic patients.[1,2,3] Apart from cardiovascular diseases, diabetic patients also have a substantial risk of developing Chronic Kidney Disease (CKD). [4,5] Reports from renal registries of many developed countries have indicated Diabetic Nephropathy as the most common cause of End Stage Renal Disease in these countries, [6,7] and the trend is evolving in many developing countries in view of the world wide growing prevalence of diabetes mellitus. [8,9] The evolution of CKD in many diabetic subjects develops from a stage of microalbuminuria defined as Albumin Creatinine Ratio (ACR) between 30 to 300mg/g, to the stage of macroalbuminuria (ACR > 300mg/24hr) with development of hypertension and progressive decline in glomerular filtration rate. [5] Most studies on Cardiovascular Diseases in Diabetic patients focused on the diabetics as a group without stratification in respect of presence or absence of nephropathy, making estimation of the contribution of nephropathy to the estimated Cardiovascular Disease burden in these studies difficult .[2] Microalbuminuria apart from being an important predictor of progression of nephropathy in diabetic patients, has also been noted to be a good marker of generalized endothelial dysfunction both in diabetic and non diabetic nephropathies. [10,11] The development of microalbuminuria substantially increases the risk of cardiovascular morbidity and mortality in diabetic as well as non diabetic patients. Recent studies have indicated that substantial cardiovascular risk may exist in patients having proteinuria in the range currently considered to be normal. [12,13,14] This risk appears to increase as the level of albuminuria increases in this setting.[14] However, most of the studies were done in the developed countries and little is known about the pattern of cardiovascular risk factors in normoalbuminuric diabetic subjects in developing countries. Hence the effect of racial and genetic influences on risk factors for diabetic nephropathy in the developing regions is largely unknown.This cross-sectional study, describes the profile of cardiovascular risk factors in normoalbumi
机译:背景糖尿病患者的肾病通常是进行性的,从微量白蛋白尿开始,逐渐发展为大蛋白尿,随后逐渐发展为肾小球滤过率降低。微量白蛋白尿的发展也大大增加了糖尿病患者发生心血管疾病的风险和死亡率。最近的研究表明,患有蛋白尿的患者可能存在大量的心血管疾病风险,目前蛋白尿水平处于正常范围。在这种情况下,这种风险似乎随着蛋白尿水平的增加而增加。但是,尚不清楚种族和遗传因素对这些观察结果的影响。方法本横断面研究描述了150名正常白蛋白尿非洲糖尿病患者的心血管危险因素的概况,这些患者在尼日利亚拉各斯一家教学医院的糖尿病门诊定期就诊。结果150名受试者中有130名(86.67%)患有一种或多种与白蛋白排泄程度无关的心血管危险因素。研究对象中有50%为高血压,肥胖者为37.3%,高胆固醇血症发生率为13.3%,LDL升高为20%,HDL较低为35.3%。糖尿病的平均病程为6.8年。结论结论:糖尿病持续时间较短的这些正常白蛋白尿患者中,心血管疾病的危险因素背景存在很高的患病率。这一发现反映了该人群中巨大的心血管疾病负担。背景技术糖尿病是心血管疾病的重要危险因素,各种研究表明,糖尿病患者心血管疾病的患病率增加,例如冠状动脉疾病,中风,周围血管疾病和充血性心力衰竭。[1,2,3]糖尿病患者也有罹患慢性肾脏病(CKD)的重大风险。 [4,5]许多发达国家的肾脏病登记处的报告表明,糖尿病肾病是这些国家最常见的终末期肾病病因,[6,7],鉴于世界范围,许多发展中国家的趋势正在发展糖尿病的广泛流行。 [8,9]在许多糖尿病患者中,CKD的演变从定义为白蛋白肌酐比率(ACR)在30至300mg / g的微量白蛋白尿阶段发展到随着高血压的发展而出现的大型白蛋白尿阶段(ACR> 300mg / 24hr)。并逐渐降低肾小球滤过率。 [5]大多数关于糖尿病患者心血管疾病的研究都集中在没有分层的糖尿病患者的存在或不存在肾病的糖尿病人群上,使得在这些研究中估计肾病对估计的心血管疾病负担的贡献非常困难。[2]微量白蛋白尿不仅是糖尿病患者肾病进展的重要预测指标,而且还被认为是糖尿病和非糖尿病肾病中普遍存在的内皮功能障碍的良好标志。 [10,11]糖尿病和非糖尿病患者中微量白蛋白尿的发展大大增加了心血管疾病发病率和死亡率的风险。最近的研究表明,患有蛋白尿的患者可能存在大量心血管疾病的风险,目前蛋白尿处于正常范围。 [12,13,14]在这种情况下,这种风险似乎随着蛋白尿水平的增加而增加。[14]但是,大多数研究是在发达国家完成的,而对发展中国家正常白蛋白尿糖尿病患者的心血管危险因素模式知之甚少。因此,种族和遗传因素对发展中地区糖尿病肾病危险因素的影响尚不清楚。这项横断面研究描述了正常白痴中心血管危险因素的概况

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号